225 related articles for article (PubMed ID: 15517700)
1. Interferon alpha-2b as adjuvant treatment of recurrent respiratory papillomatosis in Cuba: National Programme (1994-1999 report).
Nodarse-Cuní H; Iznaga-Marín N; Viera-Alvarez D; Rodríguez-Gómez H; Fernández-Fernández H; Blanco-López Y; Viada-González C; López-Saura P;
J Laryngol Otol; 2004 Sep; 118(9):681-7. PubMed ID: 15517700
[TBL] [Abstract][Full Text] [Related]
2. Use of interferon-alpha in laryngeal papillomatosis: eight years of the Cuban national programme.
Deuñas L; Alcantud V; Alvarez F; Arteaga J; Benítez A; Bopuza M; Carniege L; Cartaya B; Comas C; Cotayo R; Escobar H; Fernández H; Fernández M; Fernández R; García M; Iznaga N; la O F; Márquez J; Nordet D; Pérez J; Quintero J; Redonavich A; Robeleco M; Rodríguez H; Strander H
J Laryngol Otol; 1997 Feb; 111(2):134-40. PubMed ID: 9102438
[TBL] [Abstract][Full Text] [Related]
3. American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy.
Schraff S; Derkay CS; Burke B; Lawson L
Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1039-42. PubMed ID: 15381589
[TBL] [Abstract][Full Text] [Related]
4. [The schedule of intralesional papillomatosis treatment with cidofovir].
Szyfter W; Wierzbicka M; Jackowska J; Bartochowska A; Banaszewski J
Otolaryngol Pol; 2010; 64(2):98-102. PubMed ID: 20568538
[TBL] [Abstract][Full Text] [Related]
5. Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.
Shehab N; Sweet BV; Hogikyan ND
Pharmacotherapy; 2005 Jul; 25(7):977-89. PubMed ID: 16006276
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
Chadha NK; James A
Cochrane Database Syst Rev; 2010 Jan; (1):CD005053. PubMed ID: 20091568
[TBL] [Abstract][Full Text] [Related]
7. [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].
Neumann K; Pudszuhn A; Welzel C; Bartel-Friedrich S; Passmann M
Laryngorhinootologie; 2003 Oct; 82(10):700-6. PubMed ID: 14593568
[TBL] [Abstract][Full Text] [Related]
8. 2',5'-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis.
Gerein V; Rastorguev E; Gerein J; Lodemann E; Pfister H; Draf W; Desloovere C
J Laryngol Otol; 2004 Oct; 118(10):750-6. PubMed ID: 15550179
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
Chadha NK; James A
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD005053. PubMed ID: 23235619
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment.
Szeps M; Dahlgren L; Aaltonen LM; Öhd J; Kanter-Lewenshon L; Dahlstrand H; Munck-Wikland E; Grandér D; Dalianis T
J Gen Virol; 2005 Jun; 86(Pt 6):1695-1702. PubMed ID: 15914847
[TBL] [Abstract][Full Text] [Related]
11. Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up.
Gerein V; Rastorguev E; Gerein J; Jecker P; Pfister H
Ann Otol Rhinol Laryngol; 2005 Jun; 114(6):463-71. PubMed ID: 16042104
[TBL] [Abstract][Full Text] [Related]
12. 13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis.
Lippman SM; Donovan DT; Frankenthaler RA; Weber RS; Earley CL; Hong WK; Goepfert H
J Natl Cancer Inst; 1994 Jun; 86(11):859-61. PubMed ID: 8182767
[No Abstract] [Full Text] [Related]
13. [Treatment of laryngotracheal papillomatosis with combined use of laser surgery and intralesional administration of alpha-interferon (Roferon)].
Walther EK; Herberhold C
Laryngorhinootologie; 1993 Oct; 72(10):485-91. PubMed ID: 8267824
[TBL] [Abstract][Full Text] [Related]
14. The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma.
Navid F; Furman WL; Fleming M; Rao BN; Kovach S; Billups CA; Cain AM; Amonette R; Jenkins JJ; Pappo AS
Cancer; 2005 Feb; 103(4):780-7. PubMed ID: 15660397
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of severe respiratory papillomatosis with intravenous cidofovir and interferon alpha-2b.
Armbruster C; Kreuzer A; Vorbach H; Huber M; Armbruster C
Eur Respir J; 2001 Apr; 17(4):830-1. PubMed ID: 11401080
[TBL] [Abstract][Full Text] [Related]
16. Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study.
McMurray JS; Connor N; Ford CN
Ann Otol Rhinol Laryngol; 2008 Jul; 117(7):477-83. PubMed ID: 18700421
[TBL] [Abstract][Full Text] [Related]
17. [Current approaches to combined treatment of recurrent respiratory papillomatosis].
Pluzhnikov MS; Riabova MA; Karpishchenko SA; Katinas EB
Vestn Otorinolaringol; 2008; (4):29-37. PubMed ID: 18837150
[No Abstract] [Full Text] [Related]
18. Intralesional Cidofovir application in recurrent laryngeal papillomatosis.
Pudszuhn A; Welzel C; Bloching M; Neumann K
Eur Arch Otorhinolaryngol; 2007 Jan; 264(1):63-70. PubMed ID: 17058091
[TBL] [Abstract][Full Text] [Related]
19. [Local application of cidofovir as adjuvant therapy in recurrent laryngeal papillomatosis in children].
Pontes P; Weckx LL; Pignatari SS; Fujita RR; Avelino MA; Sato J
Rev Assoc Med Bras (1992); 2009; 55(5):581-6. PubMed ID: 19918660
[TBL] [Abstract][Full Text] [Related]
20. [Pediatric laryngeal papillomatosis: our experience (three cases)].
Rodrigo Chiner O; Gisbert Aguilar J; Sánchez Alcón MD; Morera Pérez C
Acta Otorrinolaringol Esp; 1995; 46(5):365-6. PubMed ID: 8554807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
